Finasteride Topical Delivery Systems for Androgenetic Alopecia

被引:21
|
作者
Khan, Muhammad Z. U. [1 ]
Khan, Shujaat A. [1 ]
Ubaid, Muhammad [1 ]
Shah, Aamna [1 ]
Kousar, Rozina [1 ]
Murtaza, Ghulam [1 ]
机构
[1] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan
关键词
Androgenetic alopecia; Finasteride; 5 alpha-reductase isoenzymes; Erectile dysfunction; Topical formulation; Propylene glycol; Flux; LIQUID-CRYSTALLINE NANOPARTICLES; IN-VITRO EVALUATION; PERCUTANEOUS-ABSORPTION; PROPYLENE-GLYCOL; SKIN PENETRATION; RECTAL ABSORPTION; STRATUM-CORNEUM; DRUG-DELIVERY; RAT SKIN; TRANSDERMAL PERMEATION;
D O I
10.2174/1567201815666180124112905
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Androgenetic alopecia, generally recognized as male pattern baldness, is a gradually developing medical and physiological change, which is manifested by continuous hair-loss from scalp. Finasteride (4-aza-3-oxosteroid) is a potent anti-baldness compound that selectively and competitively inhibits the 5 alpha-reductase isoenzymes. Prolonged oral use of finasteride leads to the emergence of sexual disorders including decrease in libido, gynecomastia, erectile dysfunction, ejaculation disorder, orgasm disorders and mood disturbances. Since, hair follicles widely home in 5 alpha-reductase, topical formulations of finasteride in comparison to its oral formulations are expected to potentially reduce its systemic adverse effects. The analysis of literature has revealed some delivery systems developed for the enhanced and localized penetration of finasteride into the skin. These finasteride delivery systems include polymersomes, vesicular nanocarriers, vesicular ethosomal carriers, liposomes and niosomes, liquid crystalline nanoparticles, topical solutions and gels. The aim of this review article is to briefly amass all literature on topical delivery of finasteride to elaborate best dosage form, i.e. formulation having maximum permeation rate. This study will serve as a future perspective regarding topical delivery of finasteride. The literature analysis has exhibited that most of the previous investigators have used propylene glycol in their finasteride-loaded topical formulations, while poloxamer P407, monoolein, transcutol P and choline was used in few formulations. Moreover, among all drug delivery systems, finasteride liposomal gel system consisting of 2% methyl cellulose and gel system containing poloxamer P407 exhibited the highest flux with a value of 28.4 +/- 1.3 mu g/cm(2)h and 23.1 +/- 1.4 mu g/cm(2)h, respectively. Several topical drug delivery techniques such as topical microneedles, aerosol foams, nanoemulsions, microsponges, and emulsifier free formulations, fullerenes, ointments, pastes, creams, gel and lotions are still to be worthy regarding finasteride topical delivery in future.
引用
收藏
页码:1100 / 1111
页数:12
相关论文
共 50 条
  • [1] RAMAN SPECTROSCOPY OF TOPICAL FINASTERIDE CAN DETERMINE THE POTENTIAL OF LASERASSISTED DRUG DELIVERY IN ANDROGENETIC ALOPECIA
    Patel, Payal
    Marks, Haley
    Maheshwari, Aditi
    He, Qing
    De Oliveira, Nickolas
    Buta, Martin
    Senna, Maryanne
    Manstein, Dieter
    [J]. LASERS IN SURGERY AND MEDICINE, 2023, 55 : S69 - S70
  • [2] Finasteride for female androgenetic alopecia
    Thai, KE
    Sinclair, RD
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (04) : 812 - 813
  • [3] Finasteride in androgenetic alopecia in men
    Walkowiak, Hanna
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2007, 24 (03): : 133 - 139
  • [4] Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women
    Keerti, Akshunna
    Madke, Bhushan
    Keerti, Akshaya
    Lopez, Mark Joseph C.
    Lirio, Francesca S.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [5] A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women
    Lee, Sung Won
    Juhasz, Margit
    Mobasher, Pezhman
    Ekelem, Chloe
    Mesinkovska, Natasha Atanaskova
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (04) : 457 - 463
  • [6] Topical finasteride dose evaluation for treatment of androgenetic alopecia using computer simulations
    Todeschini, D.
    Pedro Martinez, I. C.
    Duque, M. Dutra
    [J]. ANNALES PHARMACEUTIQUES FRANCAISES, 2022, 80 (02): : 169 - 175
  • [7] Effects of P-3074, a topical solution of finasteride in the treatment of androgenetic alopecia
    Caserini, M.
    Scarci, F.
    Palmieri, R.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S35 - S35
  • [8] Finasteride in the treatment of men with androgenetic alopecia
    Kaufman, KD
    Olsen, EA
    Whiting, D
    Savin, R
    DeVillez, R
    Bergfeld, W
    Price, VH
    Van Neste, D
    Roberts, JL
    Hordinsky, M
    Shapiro, J
    Binkowitz, B
    Gormley, GJ
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (04) : 578 - 589
  • [9] Guidelines on the use of finasteride in androgenetic alopecia
    Mysore, Venkataram
    Shashikumar, B. M.
    [J]. INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (02): : 128 - 134
  • [10] Pharmacodynamic of P-3074 (finasteride 0.25% topical solution) in subjects with androgenetic alopecia
    Caserini, M.
    Palmieri, R.
    Radicioni, M.
    Terragni, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (05) : 1397 - 1397